Short-term debt is larger than current assets. Quick ratio 0.64×. 2024 was 0.80×.
Opening company
COMPANY OVERVIEW
Opening company
Org. no. 931 469 851·Aksjeselskap
Legevirksomhet og utføre medisinske undersøkelser, herunder motta prøver til klinisk-kjemiske analys- er fra leger og medisinske institusjoner, samt delta i andre foretagender med tilsvarende virk- somhet.
Register details are shown now. Website, social and contact listings fill in as they are found.
firmapost@furst.noBrønnøysundregistrene email
Checking public listings
Company contact from public listings — not a verified direct line to an executive.
Loading annual accounts
Registered group structure from Brønnøysundregistrene. Ownership basis is shown as filed.
Officially registered management, board members and other roles. Each person is looked up by name on 1881 and Gulesider. A number is shown when that listing, Proff or the company website matches this person.
Org. no. 931 469 851·Aksjeselskap
Legevirksomhet og utføre medisinske undersøkelser, herunder motta prøver til klinisk-kjemiske analys- er fra leger og medisinske institusjoner, samt delta i andre foretagender med tilsvarende virk- somhet.
Company-supplied registry link. Official ownership and availability have not been independently verified.
firmapost@furst.noBrønnøysundregistrene email
Company contact from public listings — not a verified direct line to an executive.
Short-term debt is larger than current assets. Quick ratio 0.64×. 2024 was 0.80×.
Equity covers a solid share of the balance sheet. 2024 was 25%.
The company earns a healthy operating margin.
Calculated from the annual accounts filed with Brønnøysundregistrene. These bands describe the filed figures. They are not a credit rating. Changes are against the 2024 filing.
Officially registered management, board members and other roles. Each person is looked up by name on 1881 and Gulesider. A number is shown when that listing, Proff or the company website matches this person.